U.S. Physical Therapy grants director 1,210 shares

The 1,210 restricted shares vest in installments through May 20, 2027, subject to continued service as a director.

Rhea-AI Filing Summary

U S Physical Therapy Inc. (USPH) director Myra Davis acquired 1,210 shares of restricted stock under the company's Amended and Restated 2003 Stock Incentive Plan on October 1, 2026. Her reported direct holdings after the transaction were 1,210 shares. Restrictions lapse in installments: 303 shares will vest on each of November 20, 2026, and March 6, 2027, and 605 shares will vest on May 20, 2027, subject to her continued service as a director through each applicable vesting date.

Insider Trade Summary

Grant/Award: 1,210 shares

Grant/Award 1 txn

Insider Davis Myra

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock F1	1,210	$0.00	$0.00

Holdings After Transaction: Common Stock — 1,210 shares (Direct)

Footnotes (1)

1. F1. Includes 1,210 shares which were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as follows: 303 shares will vest on each of November 20, 2026, and March 6, 2027, and 605 shares will vest on May 20, 2027, subject to the Reporting Person's continued service as a director through each applicable vesting date.

Key Figures

Restricted stock grant: 1,210 shares Direct holdings after transaction: 1,210 shares Vesting installment: 303 shares +2 more

5 metrics

Restricted stock grant 1,210 shares October 1, 2026

Direct holdings after transaction 1,210 shares Reported after the October 1, 2026 transaction

Vesting installment 303 shares November 20, 2026

Vesting installment 303 shares March 6, 2027

Vesting installment 605 shares May 20, 2027

Key Terms

restricted stock, Amended and Restated 2003 Stock Incentive Plan, vest

3 terms

restricted stock financial

"granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan"

Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.

Amended and Restated 2003 Stock Incentive Plan financial

"pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan"

vest financial

"303 shares will vest on each of November 20, 2026, and March 6, 2027"

A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many shares did USPH director Myra Davis receive?

Myra Davis acquired 1,210 shares of restricted stock on October 1, 2026, under USPH's Amended and Restated 2003 Stock Incentive Plan. Her reported direct holdings after the transaction were 1,210 shares.

When do Myra Davis's USPH restricted shares vest?

The shares vest in installments: 303 shares on November 20, 2026, 303 shares on March 6, 2027, and 605 shares on May 20, 2027. Each installment is subject to her continued service as a director through its applicable vesting date.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 10/02/2026 - 04:09 PM Accepted by SEC EDGAR 10/02/2026 - 04:09 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Davis Myra

(Last) (First) (Middle)

1300 W SAM HOUSTON PKWAY S, SUITE 300

(Street)

HOUSTON TEXAS 77042

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
U S PHYSICAL THERAPY INC /NV [ USPH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
10/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	10/01/2026		A		1,210	A	$0.00	1,210(1)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Includes 1,210 shares which were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as follows: 303 shares will vest on each of November 20, 2026, and March 6, 2027, and 605 shares will vest on May 20, 2027, subject to the Reporting Person's continued service as a director through each applicable vesting date.

	/s/ Kate Venturina, as attorney-in-fact	10/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)